domingo, 31 de enero de 2016

Genetic testing for hereditary cancer predisposition: BRCA1/2, lynch syndrome, and beyond. - PubMed - NCBI

2016 Jan 23. pii: S0090-8258(16)30016-6. doi: 10.1016/j.ygyno.2016.01.019. [Epub ahead of print]

Genetic testing for hereditary cancer predisposition: BRCA1/2, lynch syndrome, and beyond.

Hall MJ1, Obeid EI2, Schwartz SC3, Mantia-Smaldone G4, Forman AD2, Daly MB2.

Author information

Abstract

Obstetrician/gynecologists and gynecologic oncologists serve an integral role in the care of women at increased hereditary risk of cancer. Their contribution includes initial identification of high risk patients, screening procedures like bimanual exam, trans-vaginal ultrasound and endometrial biopsy, prophylaxis via TAH and/or BSO, and chemoprevention. Further, gynecologists also serve a central role in the management of the secondary repercussions of efforts to mitigate increased cancer risks, including vasomotor symptoms, sexual function, bone health, cardiovascular disease, and mental health. The past several years has seen multiple new high and moderate penetrance genes introduced into the clinical care of women at increased risk of gynecologic malignancy. Awareness of these new genes and the availability of new multi-gene panel tests is critical for providers on the front-line of women's health.